# BELLINI (NCT03815890)

> Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03815890
- Phase: PHASE2
- Status: RECRUITING
- Sponsor: The Netherlands Cancer Institute
- Conditions: Breast Cancer
- Interventions: Nivolumab; Ipilimumab; Ipilimumab
- Enrollment: 80
- Primary outcome: Pathological complete response rate per cohort,

## Commentary we found

- YouTube: 38
- X threads: 29
- Podcasts: 21
- X videos: 1

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=bellini-nct03815890

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT03815890", "email": "<work email>"}; the inbox owner confirms by the emailed link.